EA201892413A1 - Стабилизированные препараты гликопептидного антибиотика - Google Patents
Стабилизированные препараты гликопептидного антибиотикаInfo
- Publication number
- EA201892413A1 EA201892413A1 EA201892413A EA201892413A EA201892413A1 EA 201892413 A1 EA201892413 A1 EA 201892413A1 EA 201892413 A EA201892413 A EA 201892413A EA 201892413 A EA201892413 A EA 201892413A EA 201892413 A1 EA201892413 A1 EA 201892413A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- glyopeptid
- stabilized
- antibiotic preparations
- antibiotic
- infusion solutions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
В заявке описаны жидкие композиции на основе гликопептидных антибиотиков или их фармацевтически приемлемых солей, при этом гликопептидный антибиотик выбран из ванкомицина, телаванцина, оритаванцина, тейкопланина и далбаванцина. Указанные композиции подходят в качестве инфузионных растворов или в качестве концентрата для приготовления инфузионных растворов.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662333357P | 2016-05-09 | 2016-05-09 | |
PCT/EP2017/060653 WO2017194385A1 (en) | 2016-05-09 | 2017-05-04 | Stabilized glycopeptide antibiotic formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201892413A1 true EA201892413A1 (ru) | 2019-05-31 |
Family
ID=58745200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201892413A EA201892413A1 (ru) | 2016-05-09 | 2017-05-04 | Стабилизированные препараты гликопептидного антибиотика |
Country Status (20)
Country | Link |
---|---|
US (1) | US10729708B2 (ru) |
EP (1) | EP3454883A1 (ru) |
JP (1) | JP6946343B2 (ru) |
KR (1) | KR20190005940A (ru) |
CN (1) | CN109069580A (ru) |
AR (1) | AR109454A1 (ru) |
AU (1) | AU2017262943B2 (ru) |
BR (1) | BR112018072948A2 (ru) |
CA (1) | CA3021935A1 (ru) |
CL (1) | CL2018003147A1 (ru) |
CO (1) | CO2018011701A2 (ru) |
EA (1) | EA201892413A1 (ru) |
IL (1) | IL262796A (ru) |
JO (2) | JOP20170111B1 (ru) |
MX (1) | MX2018013584A (ru) |
SA (1) | SA518400392B1 (ru) |
SG (1) | SG11201809908TA (ru) |
TW (2) | TWI772296B (ru) |
UY (1) | UY37233A (ru) |
WO (1) | WO2017194385A1 (ru) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2017005749A (es) | 2014-11-06 | 2018-01-11 | Xellia Pharmaceuticals Aps | Composiciones antibióticas. |
WO2021231361A1 (en) * | 2020-05-11 | 2021-11-18 | Anovent Pharmaceutical (U.S.), Llc | Pharmaceutical formulation containing active metabolites of remdesivir for inhalation |
EP4014969A1 (en) | 2020-12-16 | 2022-06-22 | EVER Valinject GmbH | Aqueous solution |
EP4014965A1 (en) | 2020-12-16 | 2022-06-22 | EVER Valinject GmbH | Aqueous solution |
CN115804832A (zh) * | 2021-09-14 | 2023-03-17 | 海南普利制药股份有限公司 | 一种万古霉素水溶液组合物 |
WO2023171588A1 (ja) * | 2022-03-08 | 2023-09-14 | 国立大学法人大阪大学 | 抗菌薬を含有するplga製剤 |
WO2023211501A1 (en) * | 2022-04-26 | 2023-11-02 | Hikma Pharmaceuticals Usa Inc. | Stable, ready-to-administer aqueous formulations of dalbavancin |
GB202207344D0 (en) | 2022-05-19 | 2022-07-06 | Arecor Ltd | Novel composition |
GB202207345D0 (en) | 2022-05-19 | 2022-07-06 | Arecor Ltd | Novel composition |
CN117618338A (zh) * | 2022-08-16 | 2024-03-01 | 海南普利制药股份有限公司 | 一种稳定的奥利万星药物水溶液及其制备方法 |
US20240139282A1 (en) * | 2022-10-12 | 2024-05-02 | Xellia Pharmaceuticals Aps | Liquid dalbavancin compositions |
WO2024079224A1 (en) * | 2022-10-12 | 2024-04-18 | Xellia Pharmaceuticals Aps | Liquid dalbavancin composition |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1278549A (en) * | 1916-12-16 | 1918-09-10 | J E Simmons | Nut and bolt lock. |
US4670258A (en) | 1984-02-10 | 1987-06-02 | Vanderbilt University | Storable prepackaged aqueous solutions of vancomycin |
US4885275A (en) | 1987-10-15 | 1989-12-05 | Eli Lilly And Company | Vancomycin-HCL solutions and the lyophilization thereof |
WO1997019690A1 (en) | 1995-12-01 | 1997-06-05 | Eli Lilly And Company | Stable vancomycin hydrochloride solutions |
JPH1180021A (ja) | 1997-09-02 | 1999-03-23 | Kayaku:Kk | バンコマイシン注射剤 |
SI1278549T1 (sl) | 2000-05-02 | 2009-04-30 | Theravance Inc | Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik |
AU2001259298A1 (en) | 2000-05-02 | 2001-11-12 | Advanced Medicine, Inc. | Polyacid glycopeptide derivatives |
KR100856479B1 (ko) | 2000-05-02 | 2008-09-04 | 세라밴스 인코포레이티드 | 환원성 알킬화 방법 |
EP2263654B1 (en) * | 2000-06-21 | 2012-10-10 | Cubist Pharmaceuticals, Inc. | Compositions for improving the oral absorption of antimicrobial agents |
UA75083C2 (ru) * | 2000-06-22 | 2006-03-15 | Тераванс, Інк. | Производные гликопептидфосфонатов |
US7034013B2 (en) | 2001-03-20 | 2006-04-25 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
US7119061B2 (en) * | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
CA2543443A1 (en) * | 2003-10-31 | 2005-05-12 | The University Of Kansas | Sulfoalkyl ether-alkyl ether cyclodextrin derivatives |
NZ555077A (en) | 2005-02-14 | 2010-03-26 | Venus Remedies Ltd | Parenteral combination therpy for infective conditions with drug resistant bacterium |
CN1857716A (zh) * | 2006-03-14 | 2006-11-08 | 浙江大学 | 注射用盐酸万古霉素及其制备方法 |
JP2008201778A (ja) | 2007-01-25 | 2008-09-04 | Mochida Pharmaceut Co Ltd | バンコマイシン液状製剤 |
EP2195004B1 (en) | 2007-09-12 | 2015-04-01 | The Medicines Company | Method of inhibiting clostridium difficile by administration of oritavancin |
US7635773B2 (en) * | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
CN102755629A (zh) * | 2012-08-02 | 2012-10-31 | 上海瑞创医药科技有限公司 | 与万古霉素形成抗菌增效包合物的组分和制备方法及其应用 |
MX2015006681A (es) | 2012-11-29 | 2016-04-06 | Insmed Inc | Formulaciones de vancomicina estabilizadas. |
CN104043104B (zh) | 2013-03-15 | 2018-07-10 | 浙江创新生物有限公司 | 含盐酸万古霉素的喷雾干粉及其工业化制备方法 |
US9616098B2 (en) | 2013-05-30 | 2017-04-11 | Scidose, Llc | Formulations of vancomycin |
MX2017005749A (es) * | 2014-11-06 | 2018-01-11 | Xellia Pharmaceuticals Aps | Composiciones antibióticas. |
EP3302494A4 (en) | 2016-01-08 | 2019-01-23 | Gufic Biosciences Limited | FREEZE-DRIED PARENTERAL COMPOSITION OF TIGECYCLIN AND METHOD FOR THE MANUFACTURE THEREOF |
RU2018129076A (ru) * | 2016-02-18 | 2020-03-18 | Мелинта Терапьютикс, Инк. | Составы оритаванцина |
-
2017
- 2017-05-04 US US16/300,137 patent/US10729708B2/en active Active
- 2017-05-04 AU AU2017262943A patent/AU2017262943B2/en not_active Ceased
- 2017-05-04 CN CN201780027315.7A patent/CN109069580A/zh active Pending
- 2017-05-04 WO PCT/EP2017/060653 patent/WO2017194385A1/en unknown
- 2017-05-04 SG SG11201809908TA patent/SG11201809908TA/en unknown
- 2017-05-04 EP EP17724773.1A patent/EP3454883A1/en not_active Withdrawn
- 2017-05-04 CA CA3021935A patent/CA3021935A1/en active Pending
- 2017-05-04 BR BR112018072948-5A patent/BR112018072948A2/pt not_active IP Right Cessation
- 2017-05-04 KR KR1020187035449A patent/KR20190005940A/ko not_active Application Discontinuation
- 2017-05-04 EA EA201892413A patent/EA201892413A1/ru unknown
- 2017-05-04 MX MX2018013584A patent/MX2018013584A/es unknown
- 2017-05-04 JP JP2018558750A patent/JP6946343B2/ja active Active
- 2017-05-07 JO JOP/2017/0111A patent/JOP20170111B1/ar active
- 2017-05-08 UY UY0001037233A patent/UY37233A/es active IP Right Grant
- 2017-05-08 AR ARP170101197A patent/AR109454A1/es unknown
- 2017-05-09 TW TW106115255A patent/TWI772296B/zh active
- 2017-05-09 TW TW110104598A patent/TWI769694B/zh active
-
2018
- 2018-10-29 CO CONC2018/0011701A patent/CO2018011701A2/es unknown
- 2018-11-05 IL IL262796A patent/IL262796A/en unknown
- 2018-11-06 CL CL2018003147A patent/CL2018003147A1/es unknown
- 2018-11-07 SA SA518400392A patent/SA518400392B1/ar unknown
-
2022
- 2022-02-17 JO JOP/2022/0039A patent/JOP20220039A1/ar unknown
Also Published As
Publication number | Publication date |
---|---|
BR112018072948A2 (pt) | 2019-02-19 |
CN109069580A (zh) | 2018-12-21 |
CL2018003147A1 (es) | 2018-12-28 |
AU2017262943A1 (en) | 2018-11-22 |
TW202133875A (zh) | 2021-09-16 |
JP6946343B2 (ja) | 2021-10-06 |
AU2017262943B2 (en) | 2020-05-14 |
TW201740955A (zh) | 2017-12-01 |
AR109454A1 (es) | 2018-12-12 |
WO2017194385A1 (en) | 2017-11-16 |
US10729708B2 (en) | 2020-08-04 |
MX2018013584A (es) | 2019-04-01 |
UY37233A (es) | 2018-01-02 |
JOP20170111B1 (ar) | 2022-03-14 |
EP3454883A1 (en) | 2019-03-20 |
CO2018011701A2 (es) | 2019-02-08 |
IL262796A (en) | 2018-12-31 |
SA518400392B1 (ar) | 2022-05-09 |
SG11201809908TA (en) | 2018-12-28 |
JOP20220039A1 (ar) | 2023-01-30 |
JP2019518733A (ja) | 2019-07-04 |
US20190175632A1 (en) | 2019-06-13 |
CA3021935A1 (en) | 2017-11-16 |
TWI769694B (zh) | 2022-07-01 |
TWI772296B (zh) | 2022-08-01 |
KR20190005940A (ko) | 2019-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201892413A1 (ru) | Стабилизированные препараты гликопептидного антибиотика | |
BR112017028413A2 (pt) | peptídeos antimicrobianos estabilizados | |
EP3980400A4 (en) | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | |
EA201890736A1 (ru) | Модуляторы корового белка вируса гепатита b | |
MX2023003461A (es) | Tratamiento de infeccion por clostridium difficile. | |
WO2017023933A3 (en) | Peptidomimetic macrocycles | |
MX2023002507A (es) | Inhibidores de cd73. | |
EP3731846A4 (en) | DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF INFECTIONS | |
MX2015015506A (es) | Peptidos antimicrobianos. | |
BR112018074985A2 (pt) | composições antibacterianas | |
BR112018010267A2 (pt) | antibióticos macrocíclicos de amplo espectro | |
BR112016023899A2 (pt) | composições compreendendo derivados de osteopontina para a inibição do crescimento do cabelo | |
EP4275759A3 (en) | Quinoline derivatives as chromobox (cbx) protein inhibitors for treating cancer | |
WO2017048699A3 (en) | Highly potent monoclonal antibodies to angiogenic factors | |
MX2021002909A (es) | Vacunas de proteinas de fusion neumococicas. | |
EP3793539A4 (en) | COMPOUNDS FOR THE TREATMENT OF DENGUE VIRUS INFECTIONS AND OTHER INFECTIONS | |
WO2018170236A9 (en) | CDPK1 INHIBITORS, COMPOSITIONS AND RELATED METHODS | |
PH12021551058A1 (en) | Antibiotic compounds, methods of manufacturing the same, pharmaceutical compositions containing the same and uses thereof | |
EP3893740A4 (en) | BLOOD FLOW RESTRICTION SYSTEM | |
WO2014176068A3 (en) | Treatment and prevention of bacterial skin infections using oritavancin | |
EA202190458A1 (ru) | Составы, содержащие дендример | |
WO2019070709A8 (en) | Compounds for treating or preventing flavivirus infections | |
EA202191343A1 (ru) | Антибиотические соединения, способы их получения, фармацевтические композиции, содержащие их, и их применение | |
MX2016011420A (es) | Peptidos horquilla beta con propiedades antivirales contra el virus dengue. | |
EA201992068A1 (ru) | Взаимодействующие с гликанами соединения и способы их применения |